Free Trial
OTCMKTS:ERGO

Entia Biosciences (ERGO) Stock Price, News & Analysis

$0.0001 0.00 (-50.00%)
As of 05/2/2025 02:13 PM Eastern

About Entia Biosciences Stock (OTCMKTS:ERGO)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0002
Volume
78,461 shs
Average Volume
50 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.

Receive ERGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Entia Biosciences and its competitors with MarketBeat's FREE daily newsletter.

ERGO Stock News Headlines

Top HDFC ERGO Health Insurance Plans
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...
Entia Biosciences, Inc. (ERGO)
Entia Biosciences Inc (ERGO)
Entia Biosciences Inc.
See More Headlines

ERGO Stock Analysis - Frequently Asked Questions

Entia Biosciences' stock was trading at $0.0002 at the beginning of the year. Since then, ERGO stock has decreased by 50.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here
.

Shares of ERGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Entia Biosciences investors own include Woodward (WWD), Drone Delivery Canada (TAKOF), Centrica (CNA), Boeing (BA) and Aurora Cannabis (ACB).

Company Calendar

Today
5/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ERGO
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
12.31
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (OTCMKTS:ERGO) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners